Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod and Sci-B-Vac in Occult Hepatitis B Infection
NCT03307902Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Oct 2016
- Primary completion
- Mar 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in hepatitis B (HBV), sponsored by The University of Hong Kong. Started Oct 2016; status: completed.
02
Drugs
imiquimod
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03307902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307902.